# HugeMed

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/hugemed

- Industry: Medical Devices & Equipment
- Headquarters: Shenzhen, China
- Website: www.hugemed.net/
- Latest round: Series C (Mar 30, 2026)
- Investors on record: 4

## About

Based in Shenzhen, China, and founded in 2014, Shenzhen HugeMed Medical Technical Development Co., Ltd. designs and manufactures video endoscopic systems for hospital use across multiple clinical departments. The company has focused on independent research and in-house manufacturing, developing both single-use and reusable endoscopes. The company is chaired by Hu Jifan. Over time, HugeMed expanded internationally, obtaining regulatory approvals including NMPA, CE MDR, FDA 510(k), and MDSAP, and establishing distribution across more than 100 countries and regions. In March 2026, HugeMed closed series C and series C+ funding rounds.

HugeMed provides video endoscopic systems for clinical diagnostics and minimally invasive procedures. Its product portfolio includes single-use and reusable video ureteroscopes and cystoscopes for urology, video bronchoscopes for pulmonary care, video rhino-laryngoscopes for ENT, video laryngoscopes for anesthesia and critical care, and colonoscopes and duodenoscopes for gastroenterology. The company supplies its products to hospitals through direct sales and distributor networks.

The company generates revenue primarily from the sale of medical devices to hospitals and healthcare institutions through domestic and international distribution channels.

The company plans to use the series C and series C+ funds to advance core endoscopic imaging and device technologies, support new product commercialization, expand large-scale manufacturing capacity, and continue international regulatory certification and global market expansion.

## Funding rounds

- Series C, Mar 30, 2026 — Qiming Venture Partners
- Series C, Mar 30, 2026 — Sunshine Life Insurance, Xiamen C&D Emerging Industry Equity Investment, Harvest Capital

## Investors

- Qiming Venture Partners (https://capitalatlas.ai/funds/qiming-venture-partners) — Series C
- Sunshine Life Insurance — Series C
- Xiamen C&D Emerging Industry Equity Investment (https://capitalatlas.ai/funds/xiamen-c-d-emerging-industry-equity-investment) — Series C
- Harvest Capital — Series C